Related Experiment Video
Updated: Jun 3, 2026

Isolation and Identification of Extravascular Immune Cells of the Heart
Published on: August 23, 2018
Infiltrative diseases of the heart
Masarrath J Moinuddin1, Vincent Figueredo, Aman M Amanullah
1Einstein Institute for Heart and Vascular Health, Albert Einstein Medical Center, and Jefferson Medical College, Philadelphia, PA, USA.
Insights
Infiltrative cardiomyopathies, including sarcoidosis, hemochromatosis, and amyloidosis, are rare restrictive heart conditions. Early diagnosis via noninvasive testing is crucial for timely treatment and improved outcomes.
Area of Science:
- Cardiology
- Cardiovascular Pathology
Background:
- Infiltrative diseases affecting the heart are a subset of restrictive cardiomyopathies.
- These conditions are rare, leading to frequent underdiagnosis and delayed treatment.
- Early diagnosis is vital to manage the detrimental effects of these cardiac pathologies.
Purpose of the Study:
- To review the prevalence of three common infiltrative cardiomyopathies: sarcoidosis, hemochromatosis, and amyloidosis.
- To summarize the pathology, diagnosis, disease progression, and therapeutic strategies for infiltrative cardiomyopathy.
- To highlight the role of noninvasive testing in diagnosing these conditions.
Main Methods:
- Literature review focusing on infiltrative cardiomyopathies.
- Analysis of prevalence data for sarcoidosis, hemochromatosis, and amyloidosis.
- Synthesis of information on diagnostic modalities, particularly noninvasive testing.
Main Results:
- Infiltrative cardiomyopathy presents a variable prognosis contingent on the underlying etiology.
- The condition is progressive and can result in premature mortality if left untreated.
- Noninvasive testing plays a significant role in the diagnostic process.
Conclusions:
- Prompt diagnosis of infiltrative cardiomyopathy is essential for effective management.
- Understanding the specific etiology guides prognosis and treatment decisions.
- Noninvasive diagnostic tools are valuable for identifying these rare cardiac conditions.
Abstract:
Infiltrative diseases targeting the cardiovascular system are a subgroup of restrictive cardiomyopathies. An early diagnosis is critical in initiating therapy to mitigate the deleterious effects of the pathologic process underlying these forms of cardiomyopathies. Infiltrative cardiac disease is rare and therefore often underdiagnosed. This review outlines the prevalence of 3 of the most common forms of restrictive cardiomyopathy: sarcoidosis, hemochromatosis, and amyloidosis. Infiltrative cardiomyopathy can have a variable prognosis depending on its etiology. It is a progressive disorder that, if left untreated, can lead to early mortality. A summary of the pathology, diagnosis, disease course, and therapy is provided, along with the utility of noninvasive testing as a means of diagnosis.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Layers of the Heart Wall
The myocardium, the thickest layer, consists of cardiac muscle cells interconnected by intercalated discs and crisscrossing connective tissue fibers. These muscle fibers contract...
Endocarditis I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis I: Introduction

